Common Contracts
2 similar License and Option Agreement contracts by Tracon Pharmaceuticals, Inc.
LICeNSE AND OPTION AGREEMENT BY AND BETWEENLicense and Option Agreement • February 16th, 2017 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This LICENSE AGREEMENT (this “Agreement”) is made and effective as of the Effective Date (as defined below) by and between TRACON Pharmaceuticals, Inc., a Delaware corporation (“TRACON”) and Janssen Pharmaceutica N.V. (“Janssen”). Each of TRACON and Janssen is sometimes referred to herein individually as a “Party” and collectively as the “Parties.” In the event a Party assigned the License and Option Agreement (as defined below) in its entirety prior to the Effective Date (as defined below) pursuant to Section 13.6 of the License and Option Agreement, or a lawful successor of a Party became bound by the License and Option Agreement prior to the Effective Date, the references to such Party in this Agreement shall be deemed to refer to such permitted assignee or lawful successor.
LICeNSE AND OPTION AGREEMENT BY AND BETWEENLicense and Option Agreement • November 9th, 2016 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This LICENSE AGREEMENT (this “Agreement”) is made and effective as of the Effective Date (as defined below) by and between TRACON Pharmaceuticals, Inc., a Delaware corporation (“TRACON”) and Janssen Pharmaceutica N.V. (“Janssen”). Each of TRACON and Janssen is sometimes referred to herein individually as a “Party” and collectively as the “Parties.” In the event a Party assigned the License and Option Agreement (as defined below) in its entirety prior to the Effective Date (as defined below) pursuant to Section 13.6 of the License and Option Agreement, or a lawful successor of a Party became bound by the License and Option Agreement prior to the Effective Date, the references to such Party in this Agreement shall be deemed to refer to such permitted assignee or lawful successor.
